Cargando...
A randomized, crossover trial comparing the efficacy and safety of fesoterodine and extended-release oxybutynin in children with overactive bladder with 12-month extension on fesoterodine: The FOXY study
INTRODUCTION: We sought to assess and compare safety and efficacy of fesoterodine and oxybutynin extended-release in the treatment of pediatric overactive bladder (OAB). METHODS: We conducted a non-inferiority, randomized, double-blind, crossover trial comparing fesoterodine 4–8 mg and oxybutynin 10...
Gardado en:
| Publicado en: | Can Urol Assoc J |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Canadian Medical Association
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7654663/ https://ncbi.nlm.nih.gov/pubmed/31977308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.6247 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|